Dermatology

 
Study Finds Dupilumab Effective for Severe Atopic Dermatitis in Real-world Setting
February 27, 2021

Dupilumab therapy for 4 weeks in adults with severe atopic dermatitis resulted in significant improvements in clinical outcomes with no adverse events reported.

10 New Drugs for Primary Care: Q4 2019
January 09, 2020

Two first-in-class migraine drugs, the first generic version of NuvaRing®, and 7 more fourth quarter FDA-approved drugs for primary care.

Dermatoses of Childhood: 7 Photoclinic Cases
November 14, 2018

Can you diagnose these 7 cases of dermatoses? Scroll through our Photoclinic to find out.